Newsletter | January 14, 2026

01.14.26 -- Life Science Connect Editors' Roundtable: Wrapping Up 2025 And Looking Ahead

FEATURED PODCAST

Editors' Roundtable: Wrapping Up 2025 And Looking Ahead

This week's special holiday episode of the Business of Biotech brings seven chief editors from the Life Science Connect family together to talk about the life sciences industry topics, trips, and reporting that mattered most in 2025, and what each editor has planned for 2026.

INDUSTRY INSIGHTS

Simple Description Of Clinical Analytics

Without teamwork, the best solutions still fall short. Unlock your clinical data's potential and transform chaos into clarity by starting with clear questions, adapting to insights, and fostering collaboration.

Validating Generative AI: A Framework For Reliability And Compliance

By providing structured, CSA-driven validation and expert guidance, organizations can harness generative AI safely and effectively — ensuring accuracy, compliance, and operational excellence.

A Framework For Improving Maternity Healthcare In The US (And Elsewhere)

The U.S. has the highest maternal mortality rate among industrialized nations. For Black women, the odds are even worse. Here's why — and what can be done.

Clinical Trial Starts Rose At Slower Pace In 2024

Clinical trial starts grew 5.5% to 10,503 in 2024, a slowdown from 2023’s 9.4% rise in trial starts. Sustained geopolitical and global regulatory pressures on pharma contributed to curbing momentum.

Built Like A Tech Company: Why CROs Need A New Operating System

See why building digital, automated infrastructure is essential, and better aligns CROs with today's speed, compliance, and innovation needs.

Continuous Manufacturing For API Breakthroughs

Discover how a chemically diverse, lead-like compound library uses advanced filtering to enhance hit discovery, accelerate hit-to-lead development, and strengthen early small‑molecule drug discovery.

From Risk To Readiness: Strategic Regulatory Support

Provide your biotech, pharma, and CDMO teams with embedded regulatory expertise to strengthen compliance, accelerate timelines, and ensure audit readiness — without adding headcount.